tiprankstipranks
Advertisement
Advertisement
CANbridge Clarifies Equity Grants to Key R&D and Regulatory Advisers
PremiumCompany AnnouncementsCANbridge Clarifies Equity Grants to Key R&D and Regulatory Advisers
2M ago
CANbridge to Raise HK$199 Million via Discounted Share Subscription Backed by WuXi Biologics Unit
Premium
Company Announcements
CANbridge to Raise HK$199 Million via Discounted Share Subscription Backed by WuXi Biologics Unit
2M ago
CANbridge Grants Share Options and RSUs Equal to 1.25% of Share Capital
Premium
Company Announcements
CANbridge Grants Share Options and RSUs Equal to 1.25% of Share Capital
3M ago
CANbridge Pharmaceuticals Proposes New General Mandate for Share Issuance
PremiumCompany AnnouncementsCANbridge Pharmaceuticals Proposes New General Mandate for Share Issuance
5M ago
CANbridge Pharmaceuticals Completes HK$22.59 Million Share Subscription
Premium
Company Announcements
CANbridge Pharmaceuticals Completes HK$22.59 Million Share Subscription
6M ago
CANbridge Pharmaceuticals to Raise HK$22.59 Million Through New Share Subscriptions
Premium
Company Announcements
CANbridge Pharmaceuticals to Raise HK$22.59 Million Through New Share Subscriptions
7M ago
CANbridge Pharmaceuticals Enhances Market Reach with Baheal Partnership
PremiumCompany AnnouncementsCANbridge Pharmaceuticals Enhances Market Reach with Baheal Partnership
8M ago
CANbridge Pharmaceuticals Announces New Share Subscription Agreement
Premium
Company Announcements
CANbridge Pharmaceuticals Announces New Share Subscription Agreement
8M ago
CANbridge Pharmaceuticals Announces Trading Halt Pending Inside Information
Premium
Company Announcements
CANbridge Pharmaceuticals Announces Trading Halt Pending Inside Information
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100